|
For Immediate Release
September 20, 2002
Washington, DC - (September 20, 2002)
- The Aspirin Foundation of America (AFA) said today
that it supports FDA's efforts to ensure the safe use
of medications like aspirin. Aspirin, which has been
used for more than one hundred years, continues to be
one of the safest and most effective analgesics available.
The AFA also said that current warnings
on aspirin product labels provide that the product is
used safely. It noted that it is unaware of any sound
scientific evidence that would warrant additional label
warnings on the product.
The statements were included in comments
submitted to FDA's Nonprescription Drug Advisory Committee
(NDAC).
"There is no evidence which indicates
that the current warnings are insufficient to allow
proper and safe use of aspirin products by consumers
or that additional label information" would be
beneficial to the public, the AFA said in its comments.
Since its inception 21 years ago, the
AFA has actively worked with FDA in developing appropriate
regulations for aspirin use as an analgesic and to reduce
the risk of conditions such as heart attack and stroke.
The AFA reiterated its continuing support for FDA's
work to protect the safety of users of analgesics.
It noted that aspirin has a
long and proven track record in safely and effectively
eliminating pain and reducing the risk of heart attack
and stroke. For more than one hundred years, millions
of consumers have safely used aspirin - which remains
the world's leading medication.
###
Contact:
Caroline Perrin
807 National Press Building, Washington, DC 20036
Phone: 800-432-3247 Fax: 202/737-8406
info@aspirin.org
|
